Attending #OCTSoutheast 10-11 March? Stop by booth \#37 to learn how we support biotechs with flexible clinical development, operational expertise and data‑driven decision‑making. https://lnkd.in/ehPmQF\_H
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Is Pharma Finally Heading for Launch Excellence?
The traditional approaches to launching a new medicine still tend to sit in the commercial function, but they need to better align with HEOR, medical affairs and clinical teams. Read more in the February issue of PME.
-
-
Rethinking Patient and Site Engagement
A thought leadership article by Dr. Nuala Murphy, President Clinical Research Services, exploring how protocol optimisation can be instrumental in improving patient and site engagement to mobilise increasingly complex clinical trials.
-
Decentralized and Hybrid Trials
An article by Gretchen Goller and Kristin Kinlaw which outlines patient feedback from a recent survey regarding the use of decentralized and hybrid trials in the pharmaceutical industry.
-
Keeping it Real: Challenges and Benefits of Integrating AI and Machine Learning into Pharma R&D
ICON's CIO Tom O'Leary provides expert commentary on integrating AI and machine learning into Pharma R&D in this January 2020 Bio IT World Article.
-
Driving Clinical Trials Forward: The Benefits of Establishing a Strategic Partnership for Flow Cytometry
A thought leadership article authored by multiple contributors from ICON’s R&D department, which focuses on the future of Flow Cytometry as a sophisticated technology.
-
The life sciences industry in Ireland
Read The Irish Times’ article featuring commentary from ICON’s Dr. Nuala Murphy on career development and workforce talent in the Life Sciences industry in Ireland.
-
A Special Report on Liver Disease: The Phantom Menace
ICON's Martin Benson provides expert commentary on liver disease in this December 2019 DDN News article.
-
The Evolving Role of the Patient in Clinical Trials
A ‘review of the year’ thought leadership article, authored by Gretchen Goller, discussing the changing role of the patient throughout 2019.
-
Using Historical Controls for Rare Disease Trials: Challenges and Opportunities
The use of historical controls in rare disease trials, using existing medical history information on a group of similar patients, rather than using a traditional placebo group, is gaining industry and regulatory support. Will Maier discusses challenges and opportunities in the Autumn 2019 issue of Pharmafile.
